you featured two papers on continuing education in rheumatology (G A Griffin, p 931; D N Golding, p 985) . I think it should be pointed out that the majority of general practitioners who are in practice today were probably not exposed to rheumatology as undergraduates and that this is still the situation with unfortunately far too many of our medical schools. I think that most of us involved in teaching undergraduate rheumatology are aware of the kind of problems that one sees in general practice and we make an effort to teach undergraduates some of these relevant skills.
I would, however, like to make two comments about the topic of continuing education in rheumatology. It strikes me that one major problem is the fact that general practitioners who attend such courses have arrived there by a process of self-selection, and I would like to know whether the ones who select themselves are the ones who already have a high standard of clinical practice. TIiere is the problem of poor attendance, which again must militate against the acquisition of proper skills in a busy clinical practice.
I would therefore like to reinforce the plea for continuing investment by the National Health Service, the universities and the Arthritis and Rheumatism Council -which has done a tremendous amount of work in this area -so that more teachers may be recruited in teaching hospitals with inadequate rheumatological facilities, that improvements may be instituted where existing rheumatological facilities are deficient and, crucially, that the full quota of consultant rheumatologists can be established. After the course or programme, the same audit has to be repeated if we are to know what effect the education has had, and repeated again if we are to know how long that effect has lasted. Few if any postgraduate centres have begun to tackle these matters.
Dr Griffin has done a real service to rheumatology. When can we expect to see similar work published in a different field, diabetes perhaps, or any of the conditions in which prescreening is appropriate and where the thrust of management is in the surgery rather than the outpatient department? Yours sincerely D G WILSON 3 January 1983
Lyophilized human amniotic membranes used in reconstruction of the ear From Dr Hugo Burgos Blond Mclndoe Centre Queen Victoria Hospital. East Grinstead and Mr Robert J Sergeant Kent and Sussex Hospital, Tunbridge Wells
Dear Sir, In response to the letter from Mr Charles A Akle (January Journal, p 82), we would like to state that lyophilized human amniotic membranes are being used to support the surgical treatment of tympanic perforations, and as a lining in mastoid cavities. Results of these investigations will be published in due course.
We have found that lyophilized amniotic membranes offer some preparatory and strategic advantages over fresh, frozen or cultured membranes. Amniotic membranes are easily lyophilized by extending them over a supporting nylon net. This allows minimum surface adherence and consequent easy detachment of the membranes after lyophilization. They are sealed in a polythene envelope, and sterilized by gamma irradiation. These lyophilized amniotic membranes fulfil the criteria for preservation of allografts described by Ironside (September 1982, p 691): sterility, non-immunogenicity, nontoxicity, adaptability to any surface, long storage and easy delivery, reconstitution and application. Besides, they release angiogenic and growthpromoting factors once reconstituted (in preparation),
Our lyophilized amniotic membranes are currently being used in the treatment of wounds, ulcers and burns at the Queen Victoria Hospital, and other hospitals in Britain and abroad. This will facilitate accumulation of data, and appraisal of their beneficial effects by independent groups. Yours faithfully
